GKIT - Innovation In Pharmaceutical And CBD Sales During Coronavirus Shut Down Is Effective Strat-egy
Virtual meetings and digital presentations are one way for pharmaceutical companies to continue to sell retailers during the coronavirus shelter-at-home edicts. This is the strategy for Bayer (NYSE: BAYRY), Pfizer (NYSE: PFE), Merck (NYSE: MRK), GlaxoSmithKline (NYSE: GSK) and Bristol Myers Squibb (NYSE: BMY). The CBD industry is no less creative, making sales to consumers digitally online as well as in the brick-and-mortar dispensaries and retailers that remain open.
The global impact of the coronavirus has intensified coverage of companies that market CBD and other health-related products. Media firms such as stockmarketpress.com feature coverage of CBD and health-related stocks such as CBD Unlimited, Inc. (OTC PINK: EDXC), Johnson & Johnson (NASDAQ: JNJ), Procter & Gamble (NYSE: PG), Canopy Growth Corp. (NYSE: CGC), New Age Beverages Corp. (NASDAQ: NBEV), GW Pharmaceuticals PLC (NASDAQ: GWPH), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT). Aurora Cannabis Inc. (NYSE:ACB) and OrganiGram Holdings Inc. (NASDAQ: OGI).
Innovation In Pharmaceutical And CBD Sales During Coronavirus Shut Down Is Effective Strategy
In-person meetings and sales are challenging in this shelter-in-place environment, so the internet is a central remote place for the major drug companies to make presentations to drug buyer decision makers at major pharmacies. CBD manufacturers are also being innovative using online internet sales to home-bound customers who want product now and limit their out-of-home visits. Innovation in pharmaceutical and CBD sales during coronavirus shut down is effective strategy.
Internet Offers CBD Companies Strategy For Making Sales
The internet online is traditionally the way some 70% of CBD product is sold as manufacturers either maintain their own sites or utilize third-party sites to sell. Remote online selling to homebound customers is a way to continue CBD sales during this stay-at-home period in more and more states. On the West Cost, one major news outlet reported that CBD retailers in California were exempted from orders for other retailer businesses to close during this pandemic. It added that CBD dispensaries were also exempted from closing due to the medical needs of patients. CBD sales may actually be increasing during the coronavirus pandemic. Innovation in pharmaceutical and CBD sales during coronavirus shut down is effective strategy.
CBD Unlimited, Inc.’s (OTC PINK: EDXC) Omni-Channel Marketing Delivers
One CBD product firm which is adapting to this changed market is CBD Unlimited, Inc. (OTC PINK: EDXC). Wisely, it adopted an omni-channel selling strategy prior, with a focus on placement on an increasing number of mass market and pharmacy shelves. The strategy has worked. It is now in major mass market chains and pharmacies, such as national chain Walgreen’s.
CBD Unlimited, Inc. (OTC PINK: EDXC) Makes An In-Demand, High Quality Product
CBD Unlimited, Inc.’s (OTC PINK: EDXC) high quality product, a healthy alternative for home-bound consumers, is important for consumers who see health as significant today. Just as they seek hand sanitizer to prevent coronavirus, they want quality in all foods they ingest. CBD is also seen globally as a product which needs to be top quality and healthy for the body.
Consumers are buying and sometimes hoarding essentials and top quality products. If they see CBD as a calming agent, they look for brand and companies that offer consistency and pure products. Firms such as CBD Unlimited, Inc. (OTC PINK: EDXC) continue the mission to expand product lines, enter into new classifications and acquire innovative and entrepreneurial companies.
CBD Unlimited, Inc. (OTC PINK: EDXC) Uses Seed-To-Shelf Strategy To Achieve Quality Control
CBD Unlimited, Inc. (OTC PINK: EDXC) ensures its CBD products are highest quality, American-manufactured and tightly controlled by a corporate seed-to-shelf manufacturing strategy. Its hemp is certified and grown in Colorado and Kentucky. It has premium genetics and superior quality, the company said in its recent Corporate Presentation. Its extracts in processing are rich in phyto-cannabinoids and terpenoids which are non-psychoactive. Product is cGMP Certified (Good Manufacturing Practice Certification).
CBD Unlimited, Inc. (OTC PINK: EDXC) Sees 70% Of CBD Industry Sales Made Online
Consumers want to make sure any products they consume is top quality. CBD Unlimited, Inc.’s (OTC PINK: EDXC) is able to do that with its seed-to-shelf marketing strategy that ensures complete control over the growing, processing and marketing process. Also, some 70% of all CBD sales are made online.Where other in-demand products may be unavailable on the shelf, but some 70% of CBD is sold online where it is available to consumers in abundance.
Source: Stock Market Press
Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Contact:
Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com Safe Harbor Statement:
Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press